Playback speed
10 seconds
ASCO 2022 Testing of a Machine Learning Model for Ability to Predict Oxaliplatin and Bevacizumab Benefit in NRG Oncology
By
ASCO 2022 Conference Coverage
FEATURING
Min Sun
By
ASCO 2022 Conference Coverage
FEATURING
Min Sun
11 views
June 16, 2022
Comments 0
Login to view comments.
Click here to Login
Recommended
AUTOPLAY